Consequences of early-onset preeclampsia on neonatal morbidity and mortality

Gustavo Rocha1

  • 1Department of Neonatology, São João University Hospital, Porto, Portugal - gusrocha@sapo.pt.

Minerva Pediatrics
|April 4, 2022
PubMed

Insights

Early-onset preeclampsia significantly impacts neonatal health, increasing risks for conditions like respiratory distress syndrome and bronchopulmonary dysplasia. Prolonging pregnancy, when safe, may improve infant outcomes.

Area of Science:

  • Neonatal Health
  • Perinatal Medicine
  • Obstetrics

Background:

  • Preterm birth is a leading cause of neonatal morbidity and mortality.
  • Early-onset preeclampsia is a common indication for preterm birth, impacting neonatal health through angiogenic and pro-inflammatory factors.
  • This review examines the neonatal consequences of early-onset preeclampsia from 2011-2021.

Approach:

  • Systematic literature review of PubMed/MEDLINE from 2011-2021.
  • Focused on studies investigating neonatal morbidity and mortality associated with early-onset preeclampsia.
  • Synthesized findings on various neonatal conditions and outcomes.

Key Points:

  • Early-onset preeclampsia is linked to fetal growth restriction (FGR) and respiratory distress syndrome (RDS).
  • Association with bronchopulmonary dysplasia (BPD) is noted, particularly in FGR cases.
  • Evidence is controversial for necrotizing enterocolitis (NEC), patent ductus arteriosus (PDA), sepsis, and intraventricular hemorrhage (IVH).
  • Preeclampsia may offer protection against periventricular leukomalacia (PVL) but not retinopathy of prematurity (ROP).
  • Hematological changes like neutropenia and thrombocytopenia are associated with preeclampsia.
  • Gestational age at birth is the primary risk factor for neonatal morbidity.

Conclusions:

  • Early-onset preeclampsia has direct consequences on neonatal morbidity.
  • Prolonging gestation in early-onset severe preeclampsia, when maternal conditions permit, can improve neonatal outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41